IE34737B1 - Amino purine derivatives - Google Patents

Amino purine derivatives

Info

Publication number
IE34737B1
IE34737B1 IE1470/70A IE147070A IE34737B1 IE 34737 B1 IE34737 B1 IE 34737B1 IE 1470/70 A IE1470/70 A IE 1470/70A IE 147070 A IE147070 A IE 147070A IE 34737 B1 IE34737 B1 IE 34737B1
Authority
IE
Ireland
Prior art keywords
amino
purine derivatives
amino purine
compounds
us3666856a
Prior art date
Application number
IE1470/70A
Other languages
English (en)
Other versions
IE34737L (en
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Priority to IE877/74A priority Critical patent/IE34738B1/xx
Publication of IE34737L publication Critical patent/IE34737L/xx
Publication of IE34737B1 publication Critical patent/IE34737B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
IE1470/70A 1969-11-17 1970-11-16 Amino purine derivatives IE34737B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IE877/74A IE34738B1 (en) 1969-11-17 1970-11-16 Amino purine derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US87744369A 1969-11-17 1969-11-17

Publications (2)

Publication Number Publication Date
IE34737L IE34737L (en) 1971-05-17
IE34737B1 true IE34737B1 (en) 1975-08-06

Family

ID=25369972

Family Applications (1)

Application Number Title Priority Date Filing Date
IE1470/70A IE34737B1 (en) 1969-11-17 1970-11-16 Amino purine derivatives

Country Status (26)

Country Link
US (1) US3666856A (ja)
JP (1) JPS5429520B1 (ja)
AT (1) AT309696B (ja)
BE (1) BE759011A (ja)
BR (1) BR6915136D0 (ja)
CA (1) CA967564A (ja)
CH (2) CH555833A (ja)
CS (1) CS181701B2 (ja)
DE (1) DE2056327C2 (ja)
DK (1) DK128117B (ja)
ES (2) ES385590A1 (ja)
FI (1) FI54315C (ja)
FR (1) FR2073364B1 (ja)
GB (2) GB1338906A (ja)
HU (1) HU163812B (ja)
IE (1) IE34737B1 (ja)
IL (1) IL35658A (ja)
LU (1) LU62071A1 (ja)
MC (1) MC869A1 (ja)
NL (1) NL171589C (ja)
NO (1) NO128156B (ja)
PL (1) PL81167B1 (ja)
SE (1) SE385374B (ja)
YU (2) YU35033B (ja)
ZA (1) ZA707722B (ja)
ZM (1) ZM12970A1 (ja)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4081534A (en) * 1973-09-11 1978-03-28 Burroughs Wellcome Co. Amino purine nucleosides as autoimmune suppressant agents
GB1562899A (en) * 1975-06-17 1980-03-19 Wellcome Found Pharmaceutical compositions containing substituted 9-( -d-arabnofuranosyl)purine-5'-phosphate and salts thereof
US4210745A (en) * 1978-01-04 1980-07-01 The United States Of America As Represented By The Department Of Health, Education And Welfare Procedure for the preparation of 9-β-D-arabinofuranosyl-2-fluoroadenine
DE3319282A1 (de) * 1983-05-27 1984-11-29 Gödecke AG, 1000 Berlin Verwendung von adenosin bei der behandlung von herpes
GB8712745D0 (en) * 1987-05-30 1987-07-01 Wellcome Found Antiviral compounds
ATE128141T1 (de) * 1988-03-16 1995-10-15 Scripps Research Inst Als therapeutische mittel verwendbare substituierte adeninderivate.
IE882585L (en) * 1988-08-25 1990-02-25 Prendergast Patrick T Viral treatment system
US5292725A (en) * 1988-08-25 1994-03-08 Prendergast Patrick T Administering particular compounds against various parasites, mycoplasmas, other indications and other infections
US5681941A (en) * 1990-01-11 1997-10-28 Isis Pharmaceuticals, Inc. Substituted purines and oligonucleotide cross-linking
US5308837A (en) * 1990-08-22 1994-05-03 Merrell Dow Pharmaceuticals Inc. 5'-amine substituted adenosine analogs as immunosuppressants
US6338963B1 (en) 1994-07-25 2002-01-15 Neotherapeutics, Inc. Use of carbon monoxide dependent guanylyl cyclase modifiers to stimulate neuritogenesis
US6232463B1 (en) 1997-10-09 2001-05-15 Isis Pharmaceuticals, Inc. Substituted purines and oligonucleotide cross-linking
WO1999057120A1 (en) 1998-05-04 1999-11-11 Neotherapeutics, Inc. Novel serotonin-like 9-substituted hypoxanthine and methods of use
US6288069B1 (en) 1999-11-16 2001-09-11 Neotherapeutics, Inc. Use of 9-substituted hypoxanthine derivatives to stimulate regeneration of nervous tissue
US6407237B1 (en) 2001-02-21 2002-06-18 Neotherapeutics, Inc. Crystal forms of 9-substituted hypoxanthine derivatives
US6849735B1 (en) 2000-06-23 2005-02-01 Merck Eprova Ag Methods of synthesis for 9-substituted hypoxanthine derivatives
ATE499103T1 (de) 2000-07-07 2011-03-15 Spectrum Pharmaceuticals Inc Verfahren zur behandlung von arzneimittelinduzierter peripherer neuropathie und verwandten krankheitsformen
US6759427B2 (en) * 2001-04-20 2004-07-06 Spectrum Pharmaceuticals, Inc. Synthesis and methods of use of tetrahydroindolone analogues and derivatives
US20030055249A1 (en) * 2001-07-17 2003-03-20 Fick David B. Synthesis and methods of use of pyrimidine analogues and derivatives
CN105237602B (zh) * 2015-06-25 2018-05-18 新乡学院 一种2-氨基阿糖腺苷的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3208997A (en) * 1962-11-15 1965-09-28 Sankyo Co Process for preparing purine and pyrimidine nucleosides
US3407191A (en) * 1966-08-29 1968-10-22 Lilly Co Eli Adamantoate esters of nucleosides
JPH1097965A (ja) * 1996-09-20 1998-04-14 Sony Corp 生産管理方法

Also Published As

Publication number Publication date
FR2073364B1 (ja) 1974-03-22
HU163812B (ja) 1973-10-27
ZA707722B (en) 1972-06-28
YU280670A (en) 1979-12-31
FR2073364A1 (ja) 1971-10-01
BE759011A (fr) 1971-05-17
DE2056327C2 (de) 1984-10-11
SE385374B (sv) 1976-06-28
DE2056327A1 (de) 1971-06-03
YU35034B (en) 1980-06-30
ES413787A1 (es) 1976-01-16
YU201978A (en) 1979-12-31
DK128117B (da) 1974-03-04
NL171589C (nl) 1983-04-18
MC869A1 (fr) 1971-09-28
IL35658A0 (en) 1971-01-28
ZM12970A1 (en) 1972-07-21
YU35033B (en) 1980-06-30
NL171589B (nl) 1982-11-16
CS181701B2 (en) 1978-03-31
LU62071A1 (ja) 1971-08-12
US3666856A (en) 1972-05-30
AT309696B (de) 1973-08-27
NL7016766A (ja) 1971-05-19
CH555833A (de) 1974-11-15
IL35658A (en) 1974-10-22
GB1338906A (en) 1973-11-28
ES385590A1 (es) 1973-10-01
CA967564A (en) 1975-05-13
NO128156B (ja) 1973-10-08
JPS5429520B1 (ja) 1979-09-25
PL81167B1 (ja) 1975-08-30
IE34737L (en) 1971-05-17
CH555344A (de) 1974-10-31
FI54315C (fi) 1978-11-10
GB1338905A (en) 1973-11-28
FI54315B (fi) 1978-07-31
BR6915136D0 (pt) 1973-04-19

Similar Documents

Publication Publication Date Title
IE34737B1 (en) Amino purine derivatives
IE34720B1 (en) Xanthone derivatives
AU1964076A (en) Salts of 1,3-bis-(8_ethylhexyl) - 5-amino-5-methyl hexahydropyrimidine
IE34742B1 (en) Cyano-phenyl-1,4-dihydropyridine derivatives
IE34794B1 (en) New sulphur-containing 1,4-dihydropyridine derivatives
ES448588A1 (es) Un procedimiento para la preparacion de un compuesto hetero-arilico.
CA982128A (en) Monostyryl-naphthalene derivatives, process for their preparation and their use as optical brighteners
IE41440L (en) Thiatetracyclines
AU468994B2 (en) 2,3-DIHYDRO-OXOIMIDAZO [1,2-a] PYRIMIDINES, THEIR ACID ADDITION SALTS THEREOF AND PROCESSES FOR THEIR PREPARATION
SE383747B (sv) Analogiforfarande for framstellning av 5-nitrofuryl-1h-pyrazolo(3,4-d)pyrimidin-4(5h)-on-derivat
CA942310A (en) Preparation of n-substituted 6,7-methylenedioxy-4-quinolone derivatives
ES465313A1 (es) Procedimiento para la obtencion de derivados de naftiridina.
IE38686L (en) 3-hydrazonomethyl rifamycin
AU464013B2 (en) Derivatives of 1,2,3,4-tetrahydropyrimidine processes for their preparation, and compositions incorporation them
IE35052L (en) Indenopyridines.
CA938294A (en) Manufacture of 1,1'-disubstituted-4,4'-bipyridylium salts
ES353671A1 (es) Procedimiento para la produccion de nuevos 1 - fenoxi-3-al-cohilaminopropanoles-(2) sustituidos.
ES374657A1 (es) Un proceso para la preparacion de nuevos derivados susti- tuidos de 1,1-dicloro-alqueno-1-.
IL37413A0 (en) Stable,storable herbicidal agent containing at least two different triazine derivatives and its production
AU8206775A (en) Novel derivatives of alkylolated amino-1,3,5-triazines
CA961460A (en) Safety harness-baby's high chair
AU2134670A (en) Manufacture of 1,1'-disubstituted -4,4'-bipyridylium salts
CA969548A (en) Preparation of n-substituted 6,7-methylenedioxy-4-quinolone derivatives
CA982575A (en) 3,5-dialkyl-4-hydroxyphenyl derivatives of triazines
CA842336A (en) Polyimides prepared from 2,6-diaminobenzo (1,2-d:5,4-d') bisthiazole